Croissance (BSE 531909)₹1.16+3.57%Residential, Commercial Projects
In the Jun 2026 quarter (consolidated), Croissance reported sales of ₹0.02 Cr and net profit of ₹0 Cr, down 100.0% year on year. For the year to Mar 2026, sales were ₹0.60 Cr and net profit ₹0.06 Cr.
Company filings, consolidated accounts; latest reported quarter Jun 2026
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.15 | 0.05 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.27 | 0.02 |
| Expenses | 0.07 | 0.04 | 0.07 | 0.10 | 0.28 | 0.21 | −0.44 | 0.11 | 0.19 | 0.19 | 0.27 | 0.10 |
| Operating Profit | 0.07 | 0.02 | −0.05 | −0.08 | −0.28 | −0.19 | 0.42 | −0.11 | −0.17 | −0.17 | 0.01 | −0.07 |
| OPM % | 49.9% | 50.0% | — | — | — | — | — | — | — | — | 7.1% | −266.7% |
| Other Income | 0.00 | 0.00 | 0.02 | 0.11 | 0.14 | −0.08 | 0.00 | 0.14 | 0.21 | 0.21 | 0.00 | 0.10 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | 0.07 | 0.02 | −0.04 | 0.00 | −0.15 | −0.26 | 0.42 | 0.00 | 0.01 | 0.01 | 0.01 | 0.00 |
| Tax % | 0.0% | 0.0% | 40.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 100.0% | 0.0% |
| Net Profit | 0.07 | 0.02 | −0.06 | 0.02 | −0.17 | −0.26 | 0.41 | 0.02 | 0.01 | 0.01 | 0.00 | 0.00 |
| EPS (Rs) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|
| Sales | 0.05 | 0.19 | 2.59 | 0.65 | 0.09 | 0.60 | 0.29 |
| Expenses | 0.02 | 0.14 | 2.00 | 0.59 | 0.16 | 0.75 | 0.75 |
| Operating Profit | 0.02 | 0.04 | 0.58 | 0.07 | −0.04 | −0.12 | −0.40 |
| OPM % | 50.0% | 25.0% | 22.7% | 12.1% | −50.0% | −21.4% | −137.9% |
| Other Income | 0.00 | 0.15 | 0.13 | 0.02 | 0.07 | 0.21 | 0.52 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | 0.02 | 0.18 | 0.70 | 0.08 | 0.00 | 0.06 | 0.03 |
| Tax % | 33.3% | 31.5% | 30.9% | 22.2% | 100.0% | 28.5% | — |
| Net Profit | 0.01 | 0.12 | 0.50 | 0.06 | 0.00 | 0.06 | 0.02 |
| EPS (Rs) | 0.00 | 0.00 | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend payout % | 0.0% | 0.0% | 0.0% | 0.0% | — | 0.0% | — |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Equity Capital | 6.86 | 6.87 | 6.87 | 6.86 | 6.86 | 6.86 |
| Reserves | 0.30 | 0.44 | 0.93 | 1.01 | 1.00 | 1.05 |
| Borrowings | 0.40 | 0.48 | 0.48 | 0.03 | 0.00 | 0.90 |
| Other Liabilities | 0.40 | 0.45 | 2.37 | 5.27 | 7.37 | 7.58 |
| Total Liabilities | 7.96 | 8.24 | 10.65 | 13.17 | 15.23 | 16.39 |
| Fixed Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 7.96 | 8.24 | 10.65 | 13.17 | 15.23 | 16.39 |
| Inventories | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.03 |
| Trade receivables | 0.00 | 0.93 | 3.38 | 3.82 | 3.82 | 3.82 |
| Cash & equivalents | 1.46 | 0.00 | 0.00 | 0.62 | 0.00 | 0.02 |
| Total Assets | 7.96 | 8.24 | 10.65 | 13.17 | 15.23 | 16.39 |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Cash from operating activity | −0.28 | −0.17 | −0.04 | 1.08 | 1.74 | −0.44 |
| Cash from investing activity | −0.11 | −0.11 | 0.06 | −0.02 | −2.36 | −0.44 |
| Cash from financing activity | 0.42 | 0.42 | 0.00 | −0.47 | −0.05 | 0.92 |
| Net cash flow | 0.00 | 0.10 | 0.00 | 0.62 | −0.62 | 0.01 |
| Free cash flow | −0.28 | −0.17 | −0.04 | 1.08 | 1.74 | −0.44 |
| CFO / OP % | −932.9% | −240.0% | 29.0% | 1,375.0% | −3,500.0% | 346.1% |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Debtor days | 0 | 1,679 | 473 | 2,107 | 13,906 | 2,280 |
| Inventory days | — | — | 0 | 0 | 0 | 103 |
| Days payable | — | — | — | — | — | 11,783 |
| Cash conversion cycle | 0 | 1,678 | 472 | 2,106 | 13,906 | −9,401 |
| Working capital days | −2,008 | 966 | 149 | 27 | −6,242 | 4,702 |
| ROCE % | — | 2.5% | 8.8% | 1.1% | 0.1% | 0.8% |
For the Jun 2026 quarter, Croissance reported sales of ₹0.02 Cr and net profit of ₹0 Cr, down 100.0% year on year. The operating margin was −266.7%.
Croissance's sales for the year to Mar 2026 were ₹0.60 Cr; over the last twelve months they were ₹0.29 Cr.
Net profit for the year to Mar 2026 was ₹0.06 Cr, and ₹0.02 Cr over the last twelve months. Earnings per share over the same trailing period were ₹0.00.
Croissance reported borrowings of ₹0.90 Cr at Mar 2026, against cash and equivalents of ₹0.02 Cr.
Cash from operations was −₹0.44 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹0.44 Cr.